Eiger BioPharmaceuticals, Inc.
Treatment of hepatitis delta virus infection
Last updated:
Abstract:
Methods of reducing hepatitis delta virus (HDV) viral loads in a patient are provided. In some embodiments, the method comprises treating the patient with lonafarnib-ritonavir co-therapy. In some embodiments, the method further comprises treating the patient with an interferon.
Status:
Grant
Type:
Utility
Filling date:
1 Aug 2018
Issue date:
10 Nov 2020